Insider · CIK 0001532133

Endicott David J.

Reports to the SEC for 5 companies · NORTHRIDGE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001532133

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-07-14	Orexigen Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2017-04-28	Zeltiq Aesthetics IncJ Other	Director	JOther	−16.1K sh	—	—	0
2016-07-12	Orexigen Therapeutics, Inc.Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2016-06-16	Zeltiq Aesthetics IncA Award	Director	AAward	+6,199 sh	$28.23	+$175K	16,132
2016-04-25	Zeltiq Aesthetics IncA Award	Director	AAward	+9,933 sh	—	—	9,933
2015-09-03	HOSPIRA INCA Award	Pres., Hospira Medical Devices	AAward	+15.2K sh	—	—	132,697
2015-09-03	HOSPIRA INCM Exercise/Conversion	Pres., Hospira Medical Devices	MExercise/Conversion	+73K sh	$43.01	+$3.14M	205,668
2015-09-03	HOSPIRA INCD Disposition to Issuer	Pres., Hospira Medical Devices	DDisposition to Issuer	−206K sh	$90.00	−$18.5M	0
2015-09-03	HOSPIRA INCStock Options (right to buy)M Exercise/Conversion	Pres., Hospira Medical Devices	MExercise/Conversion	−73K sh	—	—	0
2015-06-09	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2015-02-25	HOSPIRA INCA Award	Pres., Hospira Medical Devices	AAward	+40K sh	$87.50	+$3.5M	117,501
2013-06-05	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+18.1K sh	—	—	18,126
2013-06-05	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2013-02-21	ALLERGAN INCEmployee Stock Option (Right to Buy)A Award	CVP and President, AGN Med	AAward	+40K sh	—	—	40,000
2013-02-20	ALLERGAN INCF Tax Payment	CVP and President, AGN Med	FTax Payment	−2,794 sh	$108.08	−$302K	17,335
2013-02-15	ALLERGAN INCF Tax Payment	CVP and President, AGN Med	FTax Payment	−225 sh	$108.02	−$24.3K	20,129
2012-11-29	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	−52.6K sh	—	—	1,940
2012-11-29	ALLERGAN INCM Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	+100 sh	$64.47	+$6,447	20,452
2012-11-29	ALLERGAN INCM Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	+1,840 sh	$64.47	+$119K	22,292
2012-11-29	ALLERGAN INCS Sale	CVP and President, AGN Med	SSale	−100 sh	$92.27	−$9,227	22,192
2012-11-29	ALLERGAN INCS Sale	CVP and President, AGN Med	SSale	−1,840 sh	$92.33	−$170K	20,352
2012-11-29	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	−100 sh	—	—	1,840
2012-11-29	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	−1,840 sh	—	—	0
2012-11-29	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	−35K sh	—	—	35,000
2012-11-29	ALLERGAN INCM Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	+52.6K sh	$64.47	+$3.39M	72,912
2012-11-29	ALLERGAN INCS Sale	CVP and President, AGN Med	SSale	−52.6K sh	$92.43	−$4.86M	20,352
2012-05-07	ALLERGAN INCM Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	+15K sh	$40.16	+$602K	35,352
2012-05-07	ALLERGAN INCM Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	+12.5K sh	$59.13	+$739K	47,852
2012-05-07	ALLERGAN INCS Sale	CVP and President, AGN Med	SSale	−27.5K sh	$93.81	−$2.58M	20,352
2012-05-07	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	−15K sh	—	—	15,000
2012-05-07	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP and President, AGN Med	MExercise/Conversion	−12.5K sh	—	—	25,000
2012-02-22	ALLERGAN INCF Tax Payment	CVP and President, AGN Med	FTax Payment	−212 sh	$87.27	−$18.5K	20,352
2012-02-17	ALLERGAN INCA Award	CVP and President, AGN Med	AAward	+378 sh	—	—	20,564
2012-02-17	ALLERGAN INCEmployee Stock Option (Right to Buy)A Award	CVP and President, AGN Med	AAward	+38K sh	—	—	38,000
2012-02-17	ALLERGAN INCEmployee Stock Option (Right to Buy)A Award	CVP and President, AGN Med	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jul 184
Endicott David J.0001209191-17-045598
SEC(opens sec.gov)
Apr 284
Zeltiq Aesthetics Inc0001209191-17-028602
SEC(opens sec.gov)
Jul 144
Orexigen Therapeutics, Inc.0001209191-16-132658
SEC(opens sec.gov)
Jun 234
Zeltiq Aesthetics Inc0001209191-16-129358
SEC(opens sec.gov)
Apr 264
Zeltiq Aesthetics Inc0001209191-16-115722
SEC(opens sec.gov)
Sep 34
HOSPIRA INC0001179110-15-012965
SEC(opens sec.gov)
Jun 104
Orexigen Therapeutics, Inc.0001181431-15-008119
SEC(opens sec.gov)
Feb 274
HOSPIRA INC0001179110-15-003638
SEC(opens sec.gov)
Aug 284/A
Orexigen Therapeutics, Inc.0001181431-13-046848
SEC(opens sec.gov)
Jun 74
Orexigen Therapeutics, Inc.0001181431-13-033609
SEC(opens sec.gov)
Feb 224
Endicott David J.0001127602-13-007585
SEC(opens sec.gov)
Feb 204
Endicott David J.0001127602-13-007177
SEC(opens sec.gov)
Jan 234/A
Endicott David J.0001127602-13-002451
SEC(opens sec.gov)

Companies

Address

C/O MINIMED GROUP, INC. 18000 DEVONSHIRE STREET

NORTHRIDGE, CA, 91325